Yselty is a medicine used in adult women of childbearing age to treat: - moderate to severe symptoms of uterine fibroids, which are non-cancerous (benign) tumours of the womb (uterus); - symptoms of endometriosis, a condition where tissue similar to the endometrium (the lining of the womb) grows outside the womb. It is used in women who have already had treatment for this condition. Yselty contains the active substance linzagolix choline.
Therapeutic Indication
### Therapeutic indication Yselty is indicated in adult women of reproductive age for: - treatment of moderate to severe symptoms of uterine fibroids, - symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1).
Therapeutic Area (MeSH)
ATC Code
H01CC04
ATC Item
linzagolix
Pharmacotherapeutic Group
Pituitary and hypothalamic hormones and analogues
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| linzagolix choline | N/A | BG-2109 |
EMA Name
Yselty
Medicine Name
Yselty
Aliases
N/ANo risk management plan link.
